Warning: foreach() argument must be of type array|object, bool given in /var/www/html/web/app/themes/studypress-core-theme/template-parts/header/mobile-offcanvas.php on line 20

Sequencing the human genome and the development of microarray technology promise to improve our understanding of normal and abnormal cell behavior. How are microarrays dramatically changing our understanding of complex diseases such as cancer?

Short Answer

Expert verified
Microarrays have contributed significantly to our understanding of complex diseases like cancer by allowing researchers to analyze gene expression levels in various biological samples simultaneously. This has led to the identification of disease-related genes, the discovery of molecular signatures specific to different cancer subtypes, and a better understanding of the molecular mechanisms driving cancer progression. This knowledge has been instrumental in improving diagnostic accuracy, predicting disease progression, and tailoring personalized treatment plans for individual patients.

Step by step solution

01

Introduction to Sequencing the Human Genome and Microarray Technology

Sequencing the human genome was a major milestone in understanding human genetics and the function of genes. The process has provided us with crucial information about the structure, organization, and function of the human genome, which in turn, helped us better understand various diseases. The development of microarray technology is one of the important outcomes of genome sequencing. Microarrays play an important role in unraveling the molecular mechanisms of complex diseases like cancer.
02

Understanding Microarray Technology

Microarray technology is a high-throughput method used to analyze gene expression levels in various biological samples. A microarray is a collection of tiny spots containing DNA molecules attached to a solid surface, like a glass slide. Each DNA spot represents a unique gene, allowing simultaneous measurement of thousands of genes in a single experiment. Researchers can use the microarray to compare gene expression levels between healthy and diseased cells, helping to identify disease-related genes and their functions.
03

Microarrays and the Study of Complex Diseases

Microarray technology has been particularly useful in studying complex diseases such as cancer. Cancer is caused by mutations in genes that result in uncontrolled cell growth and division. Understanding the gene expression changes in cancer cells compared to normal cells can provide insights into the molecular mechanisms driving cancer progression and help identify potential targets for drug development.
04

Specific Examples of Microarray Contributions to Cancer Research

Microarray studies of various cancers have led to the discovery of disease-specific gene expression patterns, known as "molecular signatures." These signatures can be used for more accurate diagnosis, prediction of disease progression, and response to therapy. For example, microarray analysis of breast cancer has led to the classification of different subtypes, each with its unique molecular signature. This classification has been instrumental in choosing the appropriate treatment for individual patients and has resulted in more personalized medicine.
05

Conclusion

Overall, microarrays have dramatically changed our understanding of complex diseases, such as cancer. By allowing us to profile thousands of genes simultaneously, microarrays have significantly advanced the field of genomics and paved the way for the development of personalized medicine. The technology continues to contribute to our knowledge of disease mechanisms, ultimately helping develop more effective and targeted therapies.

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with Vaia!

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

What limits the use of differences in restriction enzyme sites as a way of detecting point mutations in human genes?

There are more than 1000 cloned farm animals in the United States. In the near future, milk from cloned cows and their offspring (born naturally) may be available in supermarkets. These cloned animals have not been transgenically modified, and they are no different than identical twins. Should milk from such animals and their natural-born offspring be labeled as coming from cloned cows or their descendants? Why?

A couple with European ancestry seeks genetic counseling before having children because of a history of cystic fibrosis (CF) in the husband's family. ASO testing for CF reveals that the husband is heterozygous for the \(\Delta 508\) mutation and that the wife is heterozygous for the \(R 117\) mutation. You are the couple's genetic counselor. When consulting with you, they express their conviction that they are not at risk for having an affected child because they each carry different mutations and cannot have a child who is homozygous for either mutation. What would you say to them?

In March 2010 Judge \(R\). Sweet ruled to invalidate Myriad Genetics' patents on the \(B R C A 1\) and \(B R C A 2\) genes. Sweet wrote that since the genes are part of the natural world, they are not patentable. Myriad Genetics also holds patents on the development of a direct-to-consumer test for the \(B R C A 1\) and \(B R C A 2\) genes. (a) Would you agree with Judge Sweet's ruling to invalidate the patenting of the \(B R C A 1\) and \(B R C A 2\) genes? If you were asked to judge the patenting of the direct-to-consumer test for the BRCA1 and BRCA2 genes, how would you rule? (b) J. Craig Venter has filed a patent application for his "firstever human made life form." This patent is designed to cover the genome of \(M\). genitalium. Would your ruling for Venter's "organism" be different from Judge Sweet's ruling on patenting of the \(B R C A 1\) and \(B R C A 2\) genes?

The first attempts at gene therapy began in 1990 with the treatment of a young girl with a genetic disorder abbreviated SCID. What does SCID stand for? In the context of SCID, what does ADA stand for?

See all solutions

Recommended explanations on Biology Textbooks

View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.

Sign-up for free